Consistently, both liver and serum levels of FGF21 were upregulated in patients with hepatitis, cirrhosis, and liver tumors, and associated with a significantly decreased survival rate in patients with inferior hepatocellular carcinoma 90. The gene discussed is FGF21; the disease is hepatocellular carcinoma.